GARDONI, FABRIZIO
GARDONI, FABRIZIO
Dipartimento di Scienze Farmacologiche e Biomolecolari
Missense variants in RPH3A cause defects in excitatory synaptic function and are associated with a clinically variable neurodevelopmental disorder
2023 L. Pavinato, J. Stanic, M. Barzasi, A. Gurgone, G. Chiantia, V. Cipriani, I. Eberini, L. Palazzolo, M. Diluca, A. Costa, A. Marcantoni, E. Biamino, M. Spada, S.M. Hiatt, W.V. Kelley, L. Vestito, S.M. Sisodiya, G. England Research Consortium, S. Efthymiou, P. Chand, R. Kaiyrzhanov, A. Bruselles, S. Cardaropoli, M. Tartaglia, S. De Rubeis, J.D. Buxbaum, D. Smedley, G.B. Ferrero, M. Giustetto, F. Gardoni, A. Brusco
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
2023 M. Mancini, S. Natoli, F. Gardoni, M. Di Luca, A. Pisani
Detection of TDP-43 seeding activity in the olfactory mucosa from patients with frontotemporal dementia
2023 E. Fontana, M. Bongianni, A. Benussi, E. Bronzato, C. Scialo, L. Sacchetto, A. Cagnin, S. Castriciano, E. Buratti, F. Gardoni, M. Italia, A. Schreiber, C. Ferracin, M. Fiorini, K.L. Newell, L. Cracco, H.J. Garringer, M.P. Cecchini, M. Polymenidou, A. Padovani, S. Monaco, G. Legname, B. Ghetti, B. Borroni, G. Zanusso
Detrimental effects of soluble α-synuclein oligomers at excitatory glutamatergic synapses
2023 E. Ferrari, M. Salvadè, E. Zianni, M. Brumana, M. Diluca, F. Gardoni
Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson’s disease restoring striatal synaptic plasticity
2023 G. Marino, F. Campanelli, G. Natale, M. De Carluccio, F. Servillo, E. Ferrari, F. Gardoni, M. Emiliana Caristo, B. Picconi, A. Cardinale, V. Loffredo, F. Crupi, E. De Leonibus, M. Teresa Viscomi, V. Ghiglieri, P. Calabresi
Antidepressant-induced increase in GluA2 expression does not translate in changes of AMPA receptor-mediated synaptic transmission at CA3/CA1 synapses in rats
2023 E. Gerace, L. Polenzani, M. Magnani, E. Zianni, G. Stocca, F. Gardoni, D.E. Pellegrini-Giampietro, R. Corradetti
Glutamatergic Treatments for Parkinson’s Disease
2022 F. Gardoni
Synaptic dysfunction in early phases of Alzheimer's Disease
2022 S. Pelucchi, F. Gardoni, M. Di Luca, E. Marcello
Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson's disease
2022 E. Ferrari, D. Scheggia, E. Zianni, M. Italia, M. Brumana, L. Palazzolo, C. Parravicini, A. Pilotto, A. Padovani, E. Marcello, I. Eberini, P. Calabresi, M. Diluca, F. Gardoni
Synaptic neurofilaments and GluN1-NfL interaction in experimental models of α-synucleinopathies
2022 A. Imarisio, E. Ferrari, A. Pilotto, M. Di Luca, A. Padovani, F. Gardoni
The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease
2022 S. Musardo, S. Therin, S. Pelucchi, L. D'Andrea, R. Stringhi, A. Ribeiro, A. Manca, C. Balducci, J. Pagano, C. Sala, C. Verpelli, V. Grieco, V. Edefonti, G. Forloni, F. Gardoni, G. Meli, D. Di Marino, M. Di Luca, E. Marcello
Reciprocal cortico-amygdala connections regulate prosocial and selfish choices in mice
2022 D. Scheggia, F. LA GRECA, F. Maltese, G. Chiacchierini, M. Italia, C. Molent, F. Bernardi, M.G. Coccia, N. Carrano, E. Zianni, F. Gardoni, M.M.G. Diluca, F. Papaleo
NMDA and AMPA Receptors at Synapses: Novel Targets for Tau and α-Synuclein Proteinopathies
2022 M. Italia, E. Ferrari, M. Diluca, F. Gardoni
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post‐Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients
2022 A.D. Maio, A. De Rosa, S. Pelucchi, M. Garofalo, B. Marciano, T. Nuzzo, F. Gardoni, A.M. Isidori, M. Di Luca, F. Errico, A. De Bartolomeis, E. Marcello, A. Usiello
Rabphilin-3A Drives Structural Modifications of Dendritic Spines Induced by Long-Term Potentiation
2022 L. Franchini, J. Stanic, M. Barzasi, E. Zianni, D. Mauceri, M. Diluca, F. Gardoni
Peptidi inibitori dell'endocitosi di ADAM10 e relativi usi nel trattamento della malattia di Alzheimer
2021 E. Marcello, M. Di Luca, S. Pelucchi, L. Vandermeulen, F. Gardoni, D. Di Marino
Protein-protein interactions at the {NMDA} receptor complex: From synaptic retention to synaptonuclear protein messengers
2021 F. Gardoni, M.M.G. Diluca
Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration
2021 M. Giunta, E. Solje, F. Gardoni, B. Borroni, A. Benussi
GluA3-containing AMPA receptors: From physiology to synaptic dysfunction in brain disorders
2021 M. Italia, E. Ferrari, M. Di Luca, F. Gardoni
Transcranial magnetic stimulation exerts “rejuvenation” effects on corticostriatal synapses after partial dopamine depletion
2021 G. Natale, A. Pignataro, G. Marino, F. Campanelli, V. Calabrese, A. Cardinale, S. Pelucchi, E. Marcello, F. Gardoni, M.T. Viscomi, B. Picconi, M. Ammassari-Teule, P. Calabresi, V. Ghiglieri